IDH2 and central nervous system cancer: Somatic mutations in the Krebs cycle enzyme isocitrate dehydrogenase (IDH) have been described in gliomas, acute myeloid leukemia, cholangiocarcinoma, melanoma, colorectal, prostate cancer, and thyroid carcinoma [20].